Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability. DiscussionHAMPEL, Martina; DALLY, Iris; WALLES, Thorsten et al.European journal of cardio-thoracic surgery. 2010, Vol 37, Num 2, pp 461-466, issn 1010-7940, 6 p.Conference Paper

A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancerMICHAEL, M; PAVLAKIS, N; CLINGAN, P et al.Oncology reports. 2012, Vol 28, Num 3, pp 763-767, issn 1021-335X, 5 p.Article

Implications of Key Trials in Advanced Nonsmall Cell Lung CancerBONOMI, Philip D.Cancer. 2010, Vol 116, Num 5, pp 1155-1164, issn 0008-543X, 10 p.Article

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trialVILMAR, A. C; SANTONI-RUGIU, E; SØRENSEN, J. B et al.Annals of oncology. 2010, Vol 21, Num 9, pp 1817-1824, issn 0923-7534, 8 p.Article

Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trialGRIDELLI, C; MANEGOLD, C; AUBERT, D et al.European journal of cancer (1990). 2004, Vol 40, Num 16, pp 2424-2431, issn 0959-8049, 8 p.Article

Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study GroupSTRØM, H. H; BREMNES, R. M; SUNDSTRØM, S. H et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1467-1475, issn 0007-0920, 9 p.Article

Safety and efficacy of weekly nab^®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerSOCINSKJ, M. A; LANGER, C. J; OKAMOTO, I et al.Annals of oncology. 2013, Vol 24, Num 2, pp 314-321, issn 0923-7534, 8 p.Article

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancerCULLEN, M. H; ZATLOUKAL, P; SÖRENSON, S et al.Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, issn 0923-7534, 7 p.Article

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study GroupFLØTTEN, O; GRØNBERG, B. H; BREMNES, R et al.British journal of cancer. 2012, Vol 107, Num 3, pp 442-447, issn 0007-0920, 6 p.Article

The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR MutationSGAMBATO, A; CASALUCE, F; CIADIELLO, F et al.Current medicinal chemistry. 2012, Vol 19, Num 20, pp 3337-3352, issn 0929-8673, 16 p.Article

An open-label study of vandetanib with pemetrexed in patients with previously treated non-small-cell lung cancerDE BOER, R; HUMBLET, Y; WOLF, J et al.Annals of oncology. 2009, Vol 20, Num 3, pp 486-491, issn 0923-7534, 6 p.Article

A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyGRIDELLI, C; GALLO, C; CERIBELLI, A et al.British journal of cancer. 2004, Vol 91, Num 12, pp 1996-2004, issn 0007-0920, 9 p.Article

Relationship between LAT1 Expression and Response to Platinum-based Chemotherapy in Non-small Cell Lung Cancer Patients with Postoperative RecurrenceKAIRA, Kyoichi; TAKAHASHI, Toshiaki; NAKAJIMA, Takashi et al.Anticancer research. 2011, Vol 31, Num 11, pp 3775-3782, issn 0250-7005, 8 p.Article

Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic reviewLIANG, Hui-Ying; HAO ZHOU; LI, Xue-Lian et al.International journal of cancer (Print). 2010, Vol 127, Num 3, pp 718-728, issn 0020-7136, 11 p.Article

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancerTAN, E. H; ROLSKI, J; ABRATT, R et al.Annals of oncology. 2009, Vol 20, Num 7, pp 1249-1256, issn 0923-7534, 8 p.Article

First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients : a multicenter phase II studyTIBALDI, C; VASILE, E; FALCONE, A et al.British journal of cancer. 2008, Vol 98, Num 3, pp 558-563, issn 0007-0920, 6 p.Article

Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility studyANDERSON, H; ADDINGTON-HALL, J. M; PEAKE, M. D et al.British journal of cancer. 2003, Vol 89, Num 12, pp 2190-2196, issn 0007-0920, 7 p.Article

Combined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLCJANTUS-LEWINTRE, Eloisa; SANMARTIN, Elena; SIRERA, Rafael et al.Lung cancer. 2011, Vol 74, Num 2, pp 326-331, issn 0169-5002, 6 p.Article

The value of [¹⁸F]fluoro-2-deoxy-n-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatmentHOEKSTRA, C. J; STROOBANTS, S. G; HOEKSTRA, O. S et al.Lung cancer. 2003, Vol 39, Num 2, pp 151-157, issn 0169-5002, 7 p.Article

Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancerCLAUDIA SACCO, Paola; MAIONE, Paolo; PALAZZOLO, Giovanni et al.Targeted oncology. 2011, Vol 6, Num 3, pp 171-180, issn 1776-2596, 10 p.Article

Combined chemo-radiotherapy for locally advanced non-small cell lung cancer : Current status and future developmentGUIDA, Cesare; MAIONE, Paolo; ROSSI, Antonio et al.Critical reviews in oncology/hematology. 2008, Vol 68, Num 3, pp 222-232, issn 1040-8428, 11 p.Article

A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancersPARK, Jinny; YONG CHAN AHN; IM, Young-Hyuck et al.Lung cancer. 2003, Vol 42, Num 2, pp 227-235, issn 0169-5002, 9 p.Article

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trialsDI MAIO, Massimo; SIGNORIELLO, Simona; DANIELE, Bruno et al.Lung cancer. 2012, Vol 76, Num 3, pp 457-464, issn 0169-5002, 8 p.Article

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating Epidermal Growth Factor Receptor mutation: Implications for clinical practice and open issuesGRIDELLI, C; DE MARINIS, F; DI MAIO, M et al.Lung cancer. 2011, Vol 72, Num 1, pp 3-8, issn 0169-5002, 6 p.Article

Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicityREINFUSS, Marian; MUCHA-MALECKA, Anna; WALASEK, Tomasz et al.Lung cancer. 2011, Vol 71, Num 3, pp 344-349, issn 0169-5002, 6 p.Article